Revenue, last quarter
$271.7M
−8.1% vs same quarter last year
Net income
$21.1M
−53.6% vs same quarter last year
EPS, diluted
$0.36
−53.8% vs same quarter last year
Operating cash flow
$41.8M
−48.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $1.1B | $95.4M |
| FY24 | $1.1B | $78.3M |
| FY23 | $1.1B | $70.4M |
| FY22 | $1.1B | $223.6M |
| FY21 | $1.2B | $414.8M |
| FY20 | $1.1B | $427.6M |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 62.6% | 22.4% | 8.8% |
| FY24 | 65.5% | 14.9% | 7% |
| FY23 | 66.9% | 19.8% | 6.3% |
| FY22 | 68.6% | 27.4% | 19.8% |
| FY21 | 68.7% | 42.2% | 35.6% |
| FY20 | 70.3% | 44.8% | 39.4% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $182.4M |
| FY24 | $19.9M |
| FY23 | $41.2M |
| FY22 | $388.6M |
| FY21 | $419.5M |
| FY20 | $456.6M |
| FY19 | - |
Show the numbers
| Year | Dividends |
|---|---|
| FY25 | $35M |
| FY24 | $34.5M |
| FY23 | $34.4M |
| FY22 | $8.6M |
| FY21 | $0 |
| FY20 | $0 |
| FY19 | - |
- Embecta Corp.
- Healthcare median
Show the numbers
| Year | Embecta Corp. | Healthcare median |
|---|---|---|
| FY25 | 8.8% | −30.6% |
| FY24 | 7% | −47% |
| FY23 | 6.3% | −58% |
| FY22 | 19.8% | −80.4% |
| FY21 | 35.6% | −71.9% |
| FY20 | 39.4% | −62.2% |
| FY19 | - | −46.3% |